Status:
COMPLETED
Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
The Ministry of Science, Technology and Innovation, Denmark
Conditions:
Obesity
Nonalcoholic Fatty Liver Disease
Eligibility:
MALE
25-65 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate potential metabolic effects of resveratrol in obese healthy men with non-alcoholic fatty liver disease. The investigators hypothesize that resveratrol will...
Eligibility Criteria
Inclusion
- Male
- 25-65 years
- Obesity (BMI \> 28 kg/m2, waist/hip ratio \> 0,95)
- Have nonalcoholic fatty liver disease (NAFLD)(intervention group) or do not have NAFLD (control group)
- May have hypertension and/or hypercholesterolemia
- Written informed consent
Exclusion
- Any other disease than NAFLD (e.g. diabetes, thyroid or parathyroid disease, heart, liver or kidney disease)
- Present and previous malignancy
- Alcohol dependency (more than 21 units of alcohol per week)
- History of smoking
- Participation in studies with radioactive isotopes within the last six months
- Hemoglobin under normal range regarding to sex (under 8.3 mmol/l for men)
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT01446276
Start Date
November 1 2011
End Date
April 1 2014
Last Update
April 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology and Internal Medicine
Aarhus C, Denmark, 8000